Skip to main content
Log in

Zweittumoren nach Bestrahlung und Chemotherapie

Auftreten von Kavernomen

Secondary tumors following radiation therapy and chemotherapy

Incidence of cavernous hemangiomas

  • Leitthema
  • Published:
Die Radiologie Aims and scope Submit manuscript

Zusammenfassung

Problem

Nach Schädelbestrahlung besteht das Risiko, sekundäre Tumoren des Zentralnervensystems (ZNS) zu entwickeln. Zunehmend werden auch Meningeome und Hypophysentumoren bestrahlt, wodurch das Risiko von Sekundärtumoren durch die Strahlentherapie bei Kindern und Erwachsenen kommuniziert werden muss.

Methodik

In Studien bei Kindern zeigt sich, dass die Bestrahlung eine 7‑ bis 10fache Zunahme nachfolgender ZNS-Tumoren mit einer kumulativen Inzidenz über 20 Jahre im Bereich von 1,03 bis 28,9 bewirkt. Die Latenzzeit für das Auftreten von Sekundärtumoren lag zwischen 5,5 und 30 Jahren, wobei sich Gliome in 5 bis 10 Jahren und Meningeome etwa 15 Jahre nach der Bestrahlung entwickelt haben. Die Latenzzeit für sekundäre ZNS-Tumoren bei Erwachsenen reichte von 5 bis 34 Jahren.

Schlussfolgerung

Nach Bestrahlung können in seltenen Fällen als Sekundärfolgen Tumoren auftreten, meist Meningeome und Gliome, aber auch Kavernome. Die Behandlung und Langzeitergebnisse von strahleninduzierten ZNS-Tumoren zeigten im Verlauf keine schlechteren Ergebnisse als primäre ZNS-Tumoren.

Abstract

Problem

There is a risk of developing secondary central nervous system (CNS) tumors after cranial radiation therapy. Meningiomas and pituitary tumors are also increasingly treated with radiation therapy, which means that the risk of secondary tumors from radiation in children and adults must be communicated.

Methods

Studies in children show that radiation causes a 7- to 10-fold increase in subsequent CNS tumors with a cumulative incidence over 20 years ranging from 1.03 to 28.9. The latency period for the occurrence of secondary tumors ranged from 5.5 to 30 years, with gliomas developing after 5–10 years and meningiomas around 15 years after irradiation. The latency period for secondary CNS tumors in adults ranged from 5 to 34 years.

Conclusion

After radiation treatment, tumors can rarely occur as secondary sequelae, mostly meningiomas and gliomas, but also cavernomas. The treatment and long-term results of radiation-induced CNS tumors showed no worse results than primary CNS tumors over the course of time.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J, Wolinsky Y, Kruchko C, Barnholtz-Sloan J (2012) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. Neuro Oncol 14(suppl 5):1–57

    Article  Google Scholar 

  2. CBTRUS (2009) 2009–2010 CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in eighteen states in 2002–2006

    Google Scholar 

  3. CBTRUS (2012) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the united states in 2004–2008 (March 23, 2012 Revision)

    Google Scholar 

  4. Petersen O (1954) Radiation cancer. Acta Radiol 42:221–236

    Article  CAS  PubMed  Google Scholar 

  5. Cahan WG, Woodard HQ, Higinbotham NL, Stewart FW, Coley BL (1998) Sarcoma arising in irradiated bone: report of eleven cases. 1948. Cancer 82:8–34

    Article  CAS  PubMed  Google Scholar 

  6. Bowers DC, Nathan PC, Constine L, Woodman C, Bhatia S, Keller K, Bashore L (2013) Subsequent neoplasms of the CNS among survivors of childhood cancer: a systematic review. Lancet Oncol 14:e321–e328

    Article  PubMed  PubMed Central  Google Scholar 

  7. Ron E, Modan B, Boice JD, Alfandary E, Stovall M, Chetrit A, Katz L (1988) Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 319:1033–1039

    Article  CAS  PubMed  Google Scholar 

  8. Walter AW, Hancock ML, Pui CH, Hudson MM, Ochs JS, Rivera GK, Pratt CB, Boyett JM, Kun LE (1998) Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children’s Research Hospital. J Clin Oncol 16:3761–3767

    Article  CAS  PubMed  Google Scholar 

  9. Tsui K, Gajjar A, Li C et al (2014) Subsequent neoplasms in survivors of childhood central nervous system tumors: risk after modern multimodal therapy. Neuro Oncol 17:448–456

    Article  PubMed  PubMed Central  Google Scholar 

  10. Tsang RW, Laperriere NJ, Simpson WJ, Brierley J, Panzarella T, Smyth HS (1993) Glioma arising after radiation therapy for pituitary adenoma. A report of four patients and estimation of risk. Cancer 72:2227–2233

    Article  CAS  PubMed  Google Scholar 

  11. Lee JW, Wernicke AG (2016) Risk and survival outcomes of radiation-induced CNS tumors. J Neurooncol 129:15–22

    Article  CAS  PubMed  Google Scholar 

  12. Löning L, Zimmermann M, Reiter A, Kaatsch P, Henze G, Riehm H, Schrappe M (2000) Secondary neoplasms subsequent to Berlin-Frankfurt-Münster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy. Blood 95:2770–2775

    Article  PubMed  Google Scholar 

  13. Breen P, Flickinger JC, Kondziolka D, Martinez AJ (1998) Radiotherapy for nonfunctional pituitary adenoma: analysis of long-term tumor control. J Neurosurg 89:933–938

    Article  CAS  PubMed  Google Scholar 

  14. Armstrong GT, Liu Q, Yasui Y et al (2009) Long-term outcomes among adult survivors of childhood central nervous system malignancies in the childhood cancer survivor study. J Natl Cancer Inst 101:946–958

    Article  PubMed  PubMed Central  Google Scholar 

  15. Hijiya N, Hudson MM, Lensing S et al (2007) Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia. JAMA 297:1207–1215

    Article  CAS  PubMed  Google Scholar 

  16. Vinchon M, Leblond P, Caron S, Delestret I, Baroncini M, Coche B (2011) Radiation-induced tumors in children irradiated for brain tumor: a longitudinal study. Childs Nerv Syst 27:445–453

    Article  PubMed  Google Scholar 

  17. Breen P, Flickinger JC, Kondziolka D, Martinez AJ (1998) Radiotherapy for nonfunctional pituitary adenoma: analysis of long-term tumor control. J Neurosurg 89:933–938

    Article  CAS  PubMed  Google Scholar 

  18. Minniti G, Traish D, Ashley S, Gonsalves A, Brada M (2005) Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years. J Clin Endocrinol Metab 90:800–804

    Article  CAS  PubMed  Google Scholar 

  19. De Gonzalez AB, Curtis RE, Kry SF, Gilbert E, Lamart S, Berg CD, Stovall M, Ron E (2011) Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries. Lancet Oncol 12:353–360

    Article  PubMed Central  Google Scholar 

  20. van Varsseveld NC, van Bunderen CC, Ubachs DHH, Franken AAM, Koppeschaar HPF, van der Lely AJ, Drent ML (2015) Cerebrovascular events, secondary intracranial tumors, and mortality after radiotherapy for nonfunctioning pituitary adenomas: a subanalysis from the Dutch National Registry of Growth Hormone Treatment in Adults. J Clin Endocrinol Metab 100:1104–1112

    Article  PubMed  Google Scholar 

  21. Shapiro S, Mealey J, Sartorius C (1989) Radiation-induced intracranial malignant gliomas. J Neurosurg 71:77–82

    Article  CAS  PubMed  Google Scholar 

  22. Carret AS, Tabori U, Crooks B, Hukin J, Odame I, Johnston DL, Keene DL, Freeman C, Bouffet E (2006) Outcome of secondary high-grade glioma in children previously treated for a malignant condition: a study of the Canadian Pediatric Brain Tumour Consortium. Radiother Oncol 81:33–38

    Article  PubMed  Google Scholar 

  23. Galloway TJ, Indelicato DJ, Amdur RJ, Swanson EL, Morris CG, Marcus RB (2011) Favorable outcomes of pediatric patients treated with radiotherapy to the central nervous system who develop radiation-induced meningiomas. Int J Radiat Oncol Biol Phys 79:117–120

    Article  PubMed  Google Scholar 

  24. Cardous-Ubbink MC, Heinen RC, Bakker PJM, van den Berg H, Oldenburger F, Caron HN, Voûte PA, van Leeuwen FE (2007) Risk of second malignancies in long-term survivors of childhoodcancer. Eur J Cancer 43:351–362

    Article  CAS  PubMed  Google Scholar 

  25. Patet G, Bartoli A, Meling TR (2022) Natural history and treatment options of radiation-induced brain cavernomas: a systematic review. Neurosurg Rev 45(1):243–251. https://doi.org/10.1007/s10143-021-01598-y

    Article  PubMed  Google Scholar 

  26. Becker L, Gebauer J, Küchler J, Staackmann C, Schacht H, Lauten M, Jensen-Kondering U, Schramm P, Langer T, Neumann A (2021) Are radiation-induced cavernomas clinically relevant findings? Results from long-term follow-up with brain magnetic resonance imaging of childhood cancer survivors. Radiol Oncol 55(3):274–283. https://doi.org/10.2478/raon-2021-0032

    Article  PubMed  PubMed Central  Google Scholar 

  27. Goshen Y, Stark B, Kornreich L, Michowiz S, Feinmesser M, Yaniv I (2007) High incidence of meningioma in cranial irradiated survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 49:294–297

    Article  PubMed  Google Scholar 

  28. Vinchon M, Leblond P, Caron S, Delestret I, Baroncini M, Coche B (2011) Radiation-induced tumors in children irradiated for brain tumor: a longitudinal study. Childs Nerv Syst 27:445–453

    Article  PubMed  Google Scholar 

Weiterführende Literatur

  1. Norberg L, Johansson R, Rasmuson T (2008) Pituitary adeno-mas in northern Sweden: a study on therapy choices and therisk of second primary tumours. Clin Endocrinol 68:780–785

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wolfgang Reith.

Ethics declarations

Interessenkonflikt

W. Reith und U. Yilmaz geben an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autor/-innen keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Additional information

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Reith, W., Yilmaz, U. Zweittumoren nach Bestrahlung und Chemotherapie. Radiologie 63, 603–608 (2023). https://doi.org/10.1007/s00117-023-01170-3

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00117-023-01170-3

Schlüsselwörter

Keywords

Navigation